AdnanNasirMD

Dermatology • Raleigh, NC

Physician

Join to view full profile

Dr. Nasir is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nasir's full profile

Already have an account?

Office
4414 Lake Boone Trl
Wake Dermatology, Suite 408
Raleigh, NC 27607
Phone+1 919-781-1001

Fax+1 919-781-3909
Is this information wrong?

Education & Training

University of North Carolina HospitalsResidency, Dermatology, 1996 - 1999
Massachusetts General HospitalInternship, Internal Medicine, 1995 - 1996
University of Rochester School of Medicine and DentistryClass of 1995

Certifications & Licensure

NC State Medical License 1996 - 2024
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FAAD) American Academy of Dermatology
Top MD Consumers Checkbook

Clinical Trials

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis Start of enrollment: 2013 Feb 01
Completed
Phase 2
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
Completed
Phase 3
A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis Start of enrollment: 2014 May 01
Completed
Phase 2
Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis Start of enrollment: 2016 Mar 01
Completed
Phase 4
Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis Start of enrollment: 2016 Apr 27
Completed
Phase 1
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity Start of enrollment: 2017 Feb 10
Completed
Phase 2
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis Start of enrollment: 2017 Sep 21
Completed
Phase 1
8-Week Atopic Dermatitis (AD) Treatment Study Start of enrollment: 2017 Nov 27
Completed
Phase 3
Cantharidin and Occlusion in Verruca Epithelium Start of enrollment: 2018 Mar 27
Completed
Phase 2
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD Start of enrollment: 2018 Apr 27
Terminated
Phase 4
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis Start of enrollment: 2018 Jun 27
Terminated
Phase 3
A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis Start of enrollment: 2019 May 30
Completed
Phase 1
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 Start of enrollment: 2020 Jul 27
Completed
Phase 3
A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2 Start of enrollment: 2020 Dec 27
Completed
Phase 3
Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) Start of enrollment: 2019 Oct 03
Completed
Phase 3
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J, ADvocate1 and ADvocat...> ;The New England journal of medicine. 2023-03-15
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K, TRuE...> ;The New England journal of medicine.
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sin...> ;The New England journal of medicine. 2022-03-26
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenber...> ;The New England journal of medicine. 2021-12-15
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal...> ;Science (New York, N.Y.). 2021-11-23
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Kehtan S, Segall N, Solis J, Brosz A, Fierro C...> ;The New England journal of medicine. 2020-12-30
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Ken...> ;The New England journal of medicine. 2021-09-22
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Blauvelt A, Kempers S, Lain E, Schlesinger T, Tyring S, Forman S, Ablon G, Martin G, Wang H, Cutler DL, Fang J, Kwan MR, Phase 3 Tirbanibulin for Actinic Keratosis Group> ;The New England journal of medicine.
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-co...
Silverberg JI, Toth D, Bieber T, Alexis AF, Elewski BE, Pink AE, Hijnen D, Jensen TN, Bang B, Olsen CK, Kurbasic A, Weidinger S, ECZTRA 3 study investigators> ;The British journal of dermatology. 2021-02-22
60 citations
Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study.
Brian S. Kim, Kang Sun, Kim A. Papp, May E. Venturanza, Adnan Nasir, Michael E. Kuligowski> ;Journal of the American Academy of Dermatology. 2020 Jun 1
119 citations
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream.
Brian S. Kim, Michael D. Howell, Kang Sun, Kim A. Papp, Adnan Nasir, Michael E. Kuligowski, Incb Study Investigators> ;The Journal of Allergy and Clinical Immunology. 2020 Feb 1
51 citations
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind C...
Angela Yen Moore, Lawrence Green, Suzanne Bruce, Neil S. Sadick, Eduardo Tschen, Philip Werschler, Fran E Cook-Bolden, Sunil Dhawan, Douglass W. Forsha, Michael H. Gol...> ;Journal of Drugs in Dermatology. 2018 Sep 1
9 citations
A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with pri...
A. Nasir, R. Bissonnette, Catherine Maari, J. DuBois, T. Pene Dumitrescu, J. Haddad, Y. Yamaguchi, M. Dalessandro> ;Journal of the European Academy of Dermatology and Venereology. 2018 Jan 1
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, ...> ;The New England journal of medicine. 2016-09-30
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntok...> ;The New England journal of medicine. 2016-06-08
37 citations
Polyglycolic acid microneedles modified with inkjet-deposited antifungal coatings
Ryan D. Boehm, Justin Daniels, Shane J. Stafslien, Adnan Nasir, Joseph Lefebvre, Roger J. Narayan> ;Biointerphases. 2015 Mar 2
4 citations
Clinical evaluation of safety and efficacy of a new topical treatment for onychomycosis.
Adnan Nasir, Beth Goldstein, Martin van Cleeff, Lance Swick> ;Journal of Drugs in Dermatology. 2011 Oct 1
141 citations
The growing role of nanotechnology in combating infectious disease.
Karin Blecher, Adnan Nasir, Adam J. Friedman> ;Virulence. 2011 Sep 1
7 citations
Nanotechnology and dermatology education in the United States: data from a pilot survey.
Adam J. Friedman, Adnan Nasir> ;Journal of Drugs in Dermatology. 2011 Sep 1
7 citations
Photonanodermatology: the interface of photobiology, dermatology and nanotechnology.
Jamie Hia, Adnan Nasir> ;Photodermatology, Photoimmunology & Photomedicine. 2011 Feb 1
13 citations
Nanotechnology and dermatology: part II--risks of nanotechnology.
Adnan Nasir> ;Clinics in Dermatology. 2010 Sep 1
7 citations
Nanodermatology: a bright glimpse just beyond the horizon - part I.
Adnan Nasir> ;Skin Therapy Letter. 2010 Sep 1
5 citations
Nanotechnology and the Nanodermatology Society.
Adnan Nasir, Adam J. Friedman> ;Journal of Drugs in Dermatology. 2010 Jul 1
16 citations
Nanotechnology and dermatology: part I--potential of nanotechnology.
Adnan Nasir> ;Clinics in Dermatology. 2010 Jul 1
15 citations
Nanotechnology in vaccine development: a step forward.
Adnan Nasir> ;The Journal of Investigative Dermatology. 2009 May 1
Join now to see all

Journal Articles

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E.L. Simpson, New England Journal of Medicine, 12/15/2016
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Gilbert PB et al, Science, 1/7/2022
Phase 3 Trials of Ixekizumab in Moderate to Severe Plaque Psoriasis
K.B. Gordon et. al., New England Journal of Medicine, 6/8/2016

Lectures

Clinical Trials in Dermatology
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

Don't Blame Creatine for Hair LossMay 18th, 2021
The Best Ways to Treat Sunburned LipsJune 18th, 2020
Nanodermatology-Based Solutions for Psoriasis: State-of-The Art and Future ProspectsNovember 1st, 2019
Join now to see all